Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» EMA Says Benefits From Pfizer’s Champix Outweigh Heart Risks
EMA Says Benefits From Pfizer’s Champix Outweigh Heart Risks
EMA Says Benefits From Pfizer’s Champix Outweigh Heart Risks
Submitted by
admin
on July 21, 2011 - 12:09pm
Source:
Bloomberg
News Tags:
Pfizer
Champix
EMA
Europe
smoking cessation
Headline:
EMA Says Benefits From Pfizer’s Champix Outweigh Heart Risks
Do Not Allow Advertisers to Use My Personal information
